Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial

This trial is studying whether adding immunotherapy (a drug that activates the immune system to fight cancer) to the standard treatment of chemotherapy and radiation helps prevent cervical cancer from coming back after surgery. It specifically focuses on patients whose cancer spread to nearby lymph nodes. **You may be eligible if...** - You have cervical cancer that was staged as FIGO 2018 stage IIIC1p or IIIC2p (meaning lymph node spread was found on pathology after surgery) - You had complete radical surgery (total removal of the uterus and affected tissue) - Your cancer tests positive for PD-L1 (a protein that suggests immunotherapy may work) - You are in good overall health (ECOG score 0 or 1) **You may NOT be eligible if...** - Cancer was found at the surgical edges (positive margins) or in the tissue surrounding the cervix - Your surgery was incomplete - There is remaining visible cancer after surgery - You have active autoimmune disease - You have previously received immunotherapy Talk to your doctor to see if this trial is right for you.